aluates Reports

$ 0.0

Automative

Global NSAIDs Drug Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-0J3316

Global NSAIDs Drug Market Insights and Forecast to 2028

BUY CHAPTERS

Global NSAIDs Drug Market Research Report 2025

Code: QYRE-Auto-0J3316

Report

September 2025

Pages:81

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

GSK

Grunenthal

Bayer

Sanofi

Eli Lilly

Astrazeneca plc

Endo

Merck

Depomed

Yunnan Baiyao

TEVA

J & J

Allergan plc

Purdue

NSAIDs Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

NSAIDs Drug Market

The global market for NSAIDs Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for NSAIDs Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NSAIDs Drug.

The NSAIDs Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NSAIDs Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the NSAIDs Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of NSAIDs Drug Market Report

Report Metric	Details
Report Name	NSAIDs Drug Market
CAGR	5%
Segment by Type	Ibuprofen Naproxen
Segment by Application	Hospitals Clinics Drugstores
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo, Merck, Depomed, Yunnan Baiyao, Teva, J&J, Allergan, Purdue
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NSAIDs Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the NSAIDs Drug Market report?

Ans: The main players in the NSAIDs Drug Market are Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo, Merck, Depomed, Yunnan Baiyao, Teva, J&J, Allergan, Purdue

What are the Application segmentation covered in the NSAIDs Drug Market report?

Ans: The Applications covered in the NSAIDs Drug Market report are Hospitals, Clinics, Drugstores

What are the Type segmentation covered in the NSAIDs Drug Market report?

Ans: The Types covered in the NSAIDs Drug Market report are Ibuprofen, Naproxen

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NSAIDs Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Ibuprofen

1.2.3 Naproxen

1.3 Market by Application

1.3.1 Global NSAIDs Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Drugstores

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global NSAIDs Drug Market Perspective (2020-2031)

2.2 Global NSAIDs Drug Growth Trends by Region

2.2.1 Global NSAIDs Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 NSAIDs Drug Historic Market Size by Region (2020-2025)

2.2.3 NSAIDs Drug Forecasted Market Size by Region (2026-2031)

2.3 NSAIDs Drug Market Dynamics

2.3.1 NSAIDs Drug Industry Trends

2.3.2 NSAIDs Drug Market Drivers

2.3.3 NSAIDs Drug Market Challenges

2.3.4 NSAIDs Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NSAIDs Drug Players by Revenue

3.1.1 Global Top NSAIDs Drug Players by Revenue (2020-2025)

3.1.2 Global NSAIDs Drug Revenue Market Share by Players (2020-2025)

3.2 Global NSAIDs Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by NSAIDs Drug Revenue

3.4 Global NSAIDs Drug Market Concentration Ratio

3.4.1 Global NSAIDs Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NSAIDs Drug Revenue in 2024

3.5 Global Key Players of NSAIDs Drug Head office and Area Served

3.6 Global Key Players of NSAIDs Drug, Product and Application

3.7 Global Key Players of NSAIDs Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 NSAIDs Drug Breakdown Data by Type

4.1 Global NSAIDs Drug Historic Market Size by Type (2020-2025)

4.2 Global NSAIDs Drug Forecasted Market Size by Type (2026-2031)

5 NSAIDs Drug Breakdown Data by Application

5.1 Global NSAIDs Drug Historic Market Size by Application (2020-2025)

5.2 Global NSAIDs Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America NSAIDs Drug Market Size (2020-2031)

6.2 North America NSAIDs Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America NSAIDs Drug Market Size by Country (2020-2025)

6.4 North America NSAIDs Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe NSAIDs Drug Market Size (2020-2031)

7.2 Europe NSAIDs Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe NSAIDs Drug Market Size by Country (2020-2025)

7.4 Europe NSAIDs Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific NSAIDs Drug Market Size (2020-2031)

8.2 Asia-Pacific NSAIDs Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific NSAIDs Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific NSAIDs Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America NSAIDs Drug Market Size (2020-2031)

9.2 Latin America NSAIDs Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America NSAIDs Drug Market Size by Country (2020-2025)

9.4 Latin America NSAIDs Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NSAIDs Drug Market Size (2020-2031)

10.2 Middle East & Africa NSAIDs Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa NSAIDs Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa NSAIDs Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer NSAIDs Drug Introduction

11.1.4 Pfizer Revenue in NSAIDs Drug Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 GSK

11.2.1 GSK Company Details

11.2.2 GSK Business Overview

11.2.3 GSK NSAIDs Drug Introduction

11.2.4 GSK Revenue in NSAIDs Drug Business (2020-2025)

11.2.5 GSK Recent Development

11.3 Grunenthal

11.3.1 Grunenthal Company Details

11.3.2 Grunenthal Business Overview

11.3.3 Grunenthal NSAIDs Drug Introduction

11.3.4 Grunenthal Revenue in NSAIDs Drug Business (2020-2025)

11.3.5 Grunenthal Recent Development

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer NSAIDs Drug Introduction

11.4.4 Bayer Revenue in NSAIDs Drug Business (2020-2025)

11.4.5 Bayer Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Sanofi Business Overview

11.5.3 Sanofi NSAIDs Drug Introduction

11.5.4 Sanofi Revenue in NSAIDs Drug Business (2020-2025)

11.5.5 Sanofi Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Details

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly NSAIDs Drug Introduction

11.6.4 Eli Lilly Revenue in NSAIDs Drug Business (2020-2025)

11.6.5 Eli Lilly Recent Development

11.7 AstraZeneca

11.7.1 AstraZeneca Company Details

11.7.2 AstraZeneca Business Overview

11.7.3 AstraZeneca NSAIDs Drug Introduction

11.7.4 AstraZeneca Revenue in NSAIDs Drug Business (2020-2025)

11.7.5 AstraZeneca Recent Development

11.8 Endo

11.8.1 Endo Company Details

11.8.2 Endo Business Overview

11.8.3 Endo NSAIDs Drug Introduction

11.8.4 Endo Revenue in NSAIDs Drug Business (2020-2025)

11.8.5 Endo Recent Development

11.9 Merck

11.9.1 Merck Company Details

11.9.2 Merck Business Overview

11.9.3 Merck NSAIDs Drug Introduction

11.9.4 Merck Revenue in NSAIDs Drug Business (2020-2025)

11.9.5 Merck Recent Development

11.10 Depomed

11.10.1 Depomed Company Details

11.10.2 Depomed Business Overview

11.10.3 Depomed NSAIDs Drug Introduction

11.10.4 Depomed Revenue in NSAIDs Drug Business (2020-2025)

11.10.5 Depomed Recent Development

11.11 Yunnan Baiyao

11.11.1 Yunnan Baiyao Company Details

11.11.2 Yunnan Baiyao Business Overview

11.11.3 Yunnan Baiyao NSAIDs Drug Introduction

11.11.4 Yunnan Baiyao Revenue in NSAIDs Drug Business (2020-2025)

11.11.5 Yunnan Baiyao Recent Development

11.12 Teva

11.12.1 Teva Company Details

11.12.2 Teva Business Overview

11.12.3 Teva NSAIDs Drug Introduction

11.12.4 Teva Revenue in NSAIDs Drug Business (2020-2025)

11.12.5 Teva Recent Development

11.13 J&J

11.13.1 J&J Company Details

11.13.2 J&J Business Overview

11.13.3 J&J NSAIDs Drug Introduction

11.13.4 J&J Revenue in NSAIDs Drug Business (2020-2025)

11.13.5 J&J Recent Development

11.14 Allergan

11.14.1 Allergan Company Details

11.14.2 Allergan Business Overview

11.14.3 Allergan NSAIDs Drug Introduction

11.14.4 Allergan Revenue in NSAIDs Drug Business (2020-2025)

11.14.5 Allergan Recent Development

11.15 Purdue

11.15.1 Purdue Company Details

11.15.2 Purdue Business Overview

11.15.3 Purdue NSAIDs Drug Introduction

11.15.4 Purdue Revenue in NSAIDs Drug Business (2020-2025)

11.15.5 Purdue Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

GSK

Grunenthal

Bayer

Sanofi

Eli Lilly

Astrazeneca plc

Endo

Merck

Depomed

Yunnan Baiyao

TEVA

J & J

Allergan plc

Purdue

List of Tables

Table 1. Global NSAIDs Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Ibuprofen

Table 3. Key Players of Naproxen

Table 4. Global NSAIDs Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global NSAIDs Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global NSAIDs Drug Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global NSAIDs Drug Market Share by Region (2020-2025)

Table 8. Global NSAIDs Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global NSAIDs Drug Market Share by Region (2026-2031)

Table 10. NSAIDs Drug Market Trends

Table 11. NSAIDs Drug Market Drivers

Table 12. NSAIDs Drug Market Challenges

Table 13. NSAIDs Drug Market Restraints

Table 14. Global NSAIDs Drug Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global NSAIDs Drug Market Share by Players (2020-2025)

Table 16. Global Top NSAIDs Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAIDs Drug as of 2024)

Table 17. Ranking of Global Top NSAIDs Drug Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by NSAIDs Drug Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of NSAIDs Drug, Headquarters and Area Served

Table 20. Global Key Players of NSAIDs Drug, Product and Application

Table 21. Global Key Players of NSAIDs Drug, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global NSAIDs Drug Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global NSAIDs Drug Revenue Market Share by Type (2020-2025)

Table 25. Global NSAIDs Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global NSAIDs Drug Revenue Market Share by Type (2026-2031)

Table 27. Global NSAIDs Drug Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global NSAIDs Drug Revenue Market Share by Application (2020-2025)

Table 29. Global NSAIDs Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global NSAIDs Drug Revenue Market Share by Application (2026-2031)

Table 31. North America NSAIDs Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America NSAIDs Drug Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America NSAIDs Drug Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe NSAIDs Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe NSAIDs Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe NSAIDs Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific NSAIDs Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific NSAIDs Drug Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific NSAIDs Drug Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America NSAIDs Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America NSAIDs Drug Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America NSAIDs Drug Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa NSAIDs Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa NSAIDs Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa NSAIDs Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Pfizer Company Details

Table 47. Pfizer Business Overview

Table 48. Pfizer NSAIDs Drug Product

Table 49. Pfizer Revenue in NSAIDs Drug Business (2020-2025) & (US$ Million)

Table 50. Pfizer Recent Development

Table 51. GSK Company Details

Table 52. GSK Business Overview

Table 53. GSK NSAIDs Drug Product

Table 54. GSK Revenue in NSAIDs Drug Business (2020-2025) & (US$ Million)

Table 55. GSK Recent Development

Table 56. Grunenthal Company Details

Table 57. Grunenthal Business Overview

Table 58. Grunenthal NSAIDs Drug Product

Table 59. Grunenthal Revenue in NSAIDs Drug Business (2020-2025) & (US$ Million)

Table 60. Grunenthal Recent Development

Table 61. Bayer Company Details

Table 62. Bayer Business Overview

Table 63. Bayer NSAIDs Drug Product

Table 64. Bayer Revenue in NSAIDs Drug Business (2020-2025) & (US$ Million)

Table 65. Bayer Recent Development

Table 66. Sanofi Company Details

Table 67. Sanofi Business Overview

Table 68. Sanofi NSAIDs Drug Product

Table 69. Sanofi Revenue in NSAIDs Drug Business (2020-2025) & (US$ Million)

Table 70. Sanofi Recent Development

Table 71. Eli Lilly Company Details

Table 72. Eli Lilly Business Overview

Table 73. Eli Lilly NSAIDs Drug Product

Table 74. Eli Lilly Revenue in NSAIDs Drug Business (2020-2025) & (US$ Million)

Table 75. Eli Lilly Recent Development

Table 76. AstraZeneca Company Details

Table 77. AstraZeneca Business Overview

Table 78. AstraZeneca NSAIDs Drug Product

Table 79. AstraZeneca Revenue in NSAIDs Drug Business (2020-2025) & (US$ Million)

Table 80. AstraZeneca Recent Development

Table 81. Endo Company Details

Table 82. Endo Business Overview

Table 83. Endo NSAIDs Drug Product

Table 84. Endo Revenue in NSAIDs Drug Business (2020-2025) & (US$ Million)

Table 85. Endo Recent Development

Table 86. Merck Company Details

Table 87. Merck Business Overview

Table 88. Merck NSAIDs Drug Product

Table 89. Merck Revenue in NSAIDs Drug Business (2020-2025) & (US$ Million)

Table 90. Merck Recent Development

Table 91. Depomed Company Details

Table 92. Depomed Business Overview

Table 93. Depomed NSAIDs Drug Product

Table 94. Depomed Revenue in NSAIDs Drug Business (2020-2025) & (US$ Million)

Table 95. Depomed Recent Development

Table 96. Yunnan Baiyao Company Details

Table 97. Yunnan Baiyao Business Overview

Table 98. Yunnan Baiyao NSAIDs Drug Product

Table 99. Yunnan Baiyao Revenue in NSAIDs Drug Business (2020-2025) & (US$ Million)

Table 100. Yunnan Baiyao Recent Development

Table 101. Teva Company Details

Table 102. Teva Business Overview

Table 103. Teva NSAIDs Drug Product

Table 104. Teva Revenue in NSAIDs Drug Business (2020-2025) & (US$ Million)

Table 105. Teva Recent Development

Table 106. J&J Company Details

Table 107. J&J Business Overview

Table 108. J&J NSAIDs Drug Product

Table 109. J&J Revenue in NSAIDs Drug Business (2020-2025) & (US$ Million)

Table 110. J&J Recent Development

Table 111. Allergan Company Details

Table 112. Allergan Business Overview

Table 113. Allergan NSAIDs Drug Product

Table 114. Allergan Revenue in NSAIDs Drug Business (2020-2025) & (US$ Million)

Table 115. Allergan Recent Development

Table 116. Purdue Company Details

Table 117. Purdue Business Overview

Table 118. Purdue NSAIDs Drug Product

Table 119. Purdue Revenue in NSAIDs Drug Business (2020-2025) & (US$ Million)

Table 120. Purdue Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. NSAIDs Drug Picture

Figure 2. Global NSAIDs Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global NSAIDs Drug Market Share by Type: 2024 VS 2031

Figure 4. Ibuprofen Features

Figure 5. Naproxen Features

Figure 6. Global NSAIDs Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global NSAIDs Drug Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Drugstores Case Studies

Figure 11. NSAIDs Drug Report Years Considered

Figure 12. Global NSAIDs Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global NSAIDs Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global NSAIDs Drug Market Share by Region: 2024 VS 2031

Figure 15. Global NSAIDs Drug Market Share by Players in 2024

Figure 16. Global Top NSAIDs Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAIDs Drug as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by NSAIDs Drug Revenue in 2024

Figure 18. North America NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America NSAIDs Drug Market Share by Country (2020-2031)

Figure 20. United States NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe NSAIDs Drug Market Share by Country (2020-2031)

Figure 24. Germany NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific NSAIDs Drug Market Share by Region (2020-2031)

Figure 32. China NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America NSAIDs Drug Market Share by Country (2020-2031)

Figure 40. Mexico NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa NSAIDs Drug Market Share by Country (2020-2031)

Figure 44. Turkey NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE NSAIDs Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Pfizer Revenue Growth Rate in NSAIDs Drug Business (2020-2025)

Figure 48. GSK Revenue Growth Rate in NSAIDs Drug Business (2020-2025)

Figure 49. Grunenthal Revenue Growth Rate in NSAIDs Drug Business (2020-2025)

Figure 50. Bayer Revenue Growth Rate in NSAIDs Drug Business (2020-2025)

Figure 51. Sanofi Revenue Growth Rate in NSAIDs Drug Business (2020-2025)

Figure 52. Eli Lilly Revenue Growth Rate in NSAIDs Drug Business (2020-2025)

Figure 53. AstraZeneca Revenue Growth Rate in NSAIDs Drug Business (2020-2025)

Figure 54. Endo Revenue Growth Rate in NSAIDs Drug Business (2020-2025)

Figure 55. Merck Revenue Growth Rate in NSAIDs Drug Business (2020-2025)

Figure 56. Depomed Revenue Growth Rate in NSAIDs Drug Business (2020-2025)

Figure 57. Yunnan Baiyao Revenue Growth Rate in NSAIDs Drug Business (2020-2025)

Figure 58. Teva Revenue Growth Rate in NSAIDs Drug Business (2020-2025)

Figure 59. J&J Revenue Growth Rate in NSAIDs Drug Business (2020-2025)

Figure 60. Allergan Revenue Growth Rate in NSAIDs Drug Business (2020-2025)

Figure 61. Purdue Revenue Growth Rate in NSAIDs Drug Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions